1. Home
  2. VYGR vs DSP Comparison

VYGR vs DSP Comparison

Compare VYGR & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

222.4M

Sector

Health Care

ML Signal

HOLD

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$11.74

Market Cap

213.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
DSP
Founded
2013
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
222.4M
213.3M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
VYGR
DSP
Price
$3.89
$11.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$17.00
$18.50
AVG Volume (30 Days)
667.5K
190.7K
Earning Date
03-10-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.49
EPS
N/A
0.10
Revenue
$31,316,000.00
$324,131,000.00
Revenue This Year
N/A
$17.79
Revenue Next Year
$71.78
$17.72
P/E Ratio
N/A
$120.03
Revenue Growth
N/A
22.97
52 Week Low
$2.65
$8.11
52 Week High
$5.78
$26.33

Technical Indicators

Market Signals
Indicator
VYGR
DSP
Relative Strength Index (RSI) 45.43 46.78
Support Level $3.86 $12.14
Resistance Level $4.11 $13.15
Average True Range (ATR) 0.25 0.63
MACD 0.01 -0.03
Stochastic Oscillator 47.79 33.02

Price Performance

Historical Comparison
VYGR
DSP

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

Share on Social Networks: